29 results
Keyword EPAR Remove keyword
Type of content
News Remove News filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B
CHMP, Last updated: 16/12/2016EMA/824717/2016 Generic Daklinza: EPAR Exviera EPAR Harvoni EPAR Olysio EPAR Sovaldi … -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020Generic Capecitabine Accord: EPAR Capecitabine Medac EPAR Capecitabine Teva EPAR Ecansya (previously Capecitabine … -
List item
Press release: EMA recommends avoidance of certain hepatitis C medicines and amiodarone together
CHMP, Last updated: 24/04/2015EMA/258577/2015 Generic Daklinza: EPAR Harvoni EPAR Sovaldi EPAR Direct-acting antivirals … -
List item
Press release: European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn
CHMP, Last updated: 18/01/2013EMA/CHMP/21862/2013 Rev Generic Pelzont: EPAR Tredaptive EPAR Trevaclyn EPAR Tredaptive: Paediatric investigation … -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020EMA/94424/2020 Generic Eliquis: EPAR Pradaxa EPAR Xarelto EPAR Pradaxa: Paediatric investigation … -
List item
Press release: No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life
CHMP, Last updated: 23/01/2019 -
List item
Press release: EMA confirms positive benefit-risk for antidepressant Valdoxan/Thymanax (agomelatine)
CHMP, Last updated: 26/09/2014EMA/577812/2014 Generic Thymanax: EPAR Valdoxan EPAR Meeting highlights from the … -
List item
Press release: European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions
CHMP, Last updated: 21/02/2014EMA/84749/2014 Generic Osseor: EPAR Protelos EPAR Osseor: Withdrawn application … -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022Sept 22, 2021. Comirnaty: EPAR Spikevax (previously COVID-19 … COVID-19 Vaccine Moderna): EPAR Comirnaty: Paediatric investigation … -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021COVID-19 Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 … COVID-19 Vaccine AstraZeneca) : EPAR - Product information PDF … -
List item
Press release: European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)
CHMP, Last updated: 21/11/2014EMA/705247/2014 Generic Corlentor: EPAR Procoralan EPAR Corlentor: Paediatric investigation … -
List item
Press release: Defect with Buccolam oral syringes
CHMP, Last updated: 15/01/2018EMA/12612/2018 Generic Buccolam: EPAR Buccolam: Paediatric investigation … -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
CHMP, Last updated: 01/06/2018EMA/355940/2018 Generic Esmya: EPAR Esmya: Article 20 procedures … -
List item
Press release: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage
CHMP, Last updated: 10/11/2017EMA/733064/2017 Generic Zinbryta: EPAR Zinbryta: Article 20 procedures … -
List item
Press release: Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
CHMP, Last updated: 20/03/2019EMA/180287/2019 Generic Xeljanz: EPAR Xeljanz: Pending EC decision … -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020EMA/228384/2020 Generic Picato: EPAR Picato: Article 20 procedures … -
List item
News: Ulipristal acetate for uterine fibroids: EMA recommends restricting use
CHMP, Last updated: 13/11/2020States in due course. Esmya: EPAR Esmya: Article 20 procedures … -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
CHMP, Last updated: 14/04/2021COVID-19 Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 … -
List item
Press release: CHMP confirms recommendations for use of Zydelig
CHMP, Last updated: 22/07/2016EMA/488322/2016 Generic Zydelig: EPAR Zydelig: Withdrawn application … -
List item
Press release: European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots
CHMP, Last updated: 22/11/2013Iclusig: EPAR Iclusig: Paediatric investigation … -
List item
Press release: European Medicines Agency recommends restricting Trobalt to last-line therapy in partial epilepsy
CHMP, Last updated: 31/05/2013Trobalt: EPAR Trobalt: Paediatric investigation … -
List item
Press release: Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada
CHMP, Last updated: 15/11/2019EMA/609015/2019 Generic Lemtrada: EPAR Lemtrada: Paediatric investigation … -
List item
Press release: EMA recommends measures to ensure safe use of Keppra oral solution
CHMP, Last updated: 14/10/2016Keppra: EPAR … -
List item
News: EMA recommends restricting use of cancer medicine Rubraca
CHMP, Last updated: 22/07/2022Rubraca: EPAR Rubraca: Paediatric investigation … -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018Xofigo: EPAR Xofigo: Paediatric investigation …